Tensions in ethics and policy created by National Precision Medicine Programs
Open Access
- 17 April 2018
- journal article
- research article
- Published by Springer Nature in Human Genomics
- Vol. 12 (1) , 22
Abstract
Precision medicine promises to use genomics and other data-intensive approaches to improve diagnosis and develop new treatments for major diseases, but also raises a range of ethical and governance challenges. Implementation of precision medicine in “real world” healthcare systems blurs the boundary between research and care. This has implications for the meaning and validity of consent, and increased potential for discrimination, among other challenges. Increased sharing of personal information raises concerns about privacy, commercialization, and public trust. This paper considers national precision medicine schemes from the USA, the UK, and Japan, comparing how these challenges manifest in each national context and examining the range of approaches deployed to mitigate the potential undesirable social consequences. There is rarely a “one size” fits all solution to these complex problems, but the most viable approaches are those which take account of cultural preferences and attitudes, available resources, and the wider political landscape in which national healthcare systems are embedded.Keywords
Funding Information
- Research Institute of Science and Technology for Society (15K19149)
- Economic and Social Research Council (ES/P002943/1)
This publication has 58 references indexed in Scilit:
- Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and GenomicsGenetics in Medicine, 2017
- Implementing Precision Medicine: The Ethical ChallengesTrends in Pharmacological Sciences, 2017
- Stratified, precision or personalised medicine? Cancer services in the ‘real world’ of a London hospitalSociology of Health & Illness, 2016
- The DNA of a nationNature, 2015
- A New Initiative on Precision MedicineNew England Journal of Medicine, 2015
- Ethical, Legal and Social Implications of Incorporating Personalized Medicine into HealthcarePersonalized Medicine, 2015
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013
- Whole-genome sequencing in health careEuropean Journal of Human Genetics, 2013
- Implementing genomic medicine in the clinic: the future is hereGenetics in Medicine, 2013
- Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkersNature Reviews Drug Discovery, 2007